Emex 3,0 g/5 mL Syrup
PDF Leaflet Revision Date: 21 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic relief of nausea in motion sickness and early pregnancy.
Dosage (summary)
Adults: 15-30 mL every 15 mins for max 1 hour. Children (3+ years): 5-10 mL every 15 mins for max 1 hour.
Special Populations
- Renal failure
- Diabetes
- Hereditary fructose intolerance
Pregnancy & Breastfeeding
No data on safety during pregnancy and lactation.
Contraindications
- Methyl alcohol poisoning
- Renal failure
- Diabetes
- Hereditary fructose intolerance
Common side effects
- No side effects reported
Counselling Points
- Do not dilute dosage.
- Avoid fluids immediately before or after dosing.
Serious warnings
- Do not exceed 5 doses in 1 hour without consulting a doctor.
- Consult a physician if nausea persists.
Important Disclaimer
The Emex 3,0 g/5 mL Syrup professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
Clinical Particulars
Section 4 of the official insert — extracted exactly as issued, no alterations
4.1 Therapeutic indications
EMEX is indicated for the symptomatic relief of nausea in motion sickness and in early pregnancy.
4.2 Posology and method of administration
Posology
Motion sickness (car, air, etc.):
Adults: Three to six (15 to 30 mL) medicine measures. Dose may be repeated every fifteen minutes until distress subsides but should not be taken for more than one hour (five doses) without consulting a doctor.
Children over 3 years of age: One to two (5 to 10 mL) medicine measures. Dose may be repeated every fifteen minutes until distress subsides but should not be taken for more than one hour (five doses) without consulting a doctor.
Morning sickness:
Three to six (15 to 30 mL) medicine measures. Dose should be taken on arising and repeated every three hours as needed.
Paediatric population
Children under 3 years of age: Use is not recommended.
Method of administration
Do not dilute the dosage since the optimal pH for functioning will be destroyed. Oral fluids should not be taken immediately before or for at least 15 minutes after the dose.
4.3 Contraindications
EMEX should not be used in:
u2022 Patients suffering from methyl alcohol poisoning
u2022 Renal failure
u2022 Diabetes
u2022 Hereditary fructose intolerance.
4.4 Special warnings and precautions for use
EMEX syrup must not be taken for more than 1 hour (5 doses) without consulting a doctor. If nausea continues or recurs frequently, consult a physician promptly since this may be a sign of a serious condition.
Fluids must not be taken immediately prior to or for at least 15 minutes after a dosage of EMEX because of the diluting effects.
Patients with rare hereditary problems of fructose intolerance or glucose-galactose malabsorption should not take this medicine.
4.5 Interaction with other medicines and other forms of interaction
EMEX is not known to interact with other medicines. No interaction studies have been performed.
4.6 Fertility, pregnancy and lactation
There are no data on fertility, pregnancy and lactation.
4.7 Effects on ability to drive and use machines
EMEX has no effect on the ability to drive and use machines.
4.8 Undesirable effects
EMEX produces no side effects.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicine is important. It allows continued monitoring of the benefit/risk balance of the medicine. Health care providers are asked to report any suspected adverse reactions to SAHPRA via the u201c6.04 Adverse Drug Reactions Reporting Formu201d, found online under SAHPRAu2019s publications: https://www.sahpra.org.za/Publications/Index/8 and to Cipla Medpro (Pty) Ltd at [email protected] or telephone 080 222 6662 (toll free).
4.9 Overdose
EMEX is a safe and non-toxic medicine.
